CERO THERAPEUTICS HOLDINGS I (CERO)
US71902K1051 - Common Stock
Top movers in Friday's after hours session
After hours stock analysis on 2024-11-15: top gainers and losers in today's session.
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.
Which stocks are experiencing notable movement on Friday?
Discover the most active stocks in Friday's session. Stay informed about the stocks that are generating the most trading volume!
Let's have a look at the most active stocks in today's session.
Which stocks have an unusual volume on Friday?
On Friday, there are stocks with unusual volume. Let's take a look.
Here are the top movers in Friday's session, showcasing the stocks with significant price changes.
Top movers analysis in the middle of the day on 2024-11-15: top gainers and losers in today's session.
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday.
Let's have a look at the gap up and gap down stocks in today's session.
CERo Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound CER-1236 in Acute Myelogenous Leukemia
SOUTH SAN FRANCISCO, Calif, Nov. 15, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy...
Curious about the stocks that are showing activity before the opening bell on Thursday?
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Stay up-to-date with the latest market trends one hour before the close of the markets on Tuesday. Explore the top gainers and losers during today's session in our detailed report.
Most active stocks in Tuesday's session
Let's dive into the action on the US markets on Tuesday. Here are the most active stocks that are driving the market today.
Which stocks have an unusual volume on Tuesday?
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the stocks with an unusual volume in today's session.
Get insights into the top gainers and losers of Monday's after-hours session.
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Which stocks are experiencing notable movement on Monday?
Looking for insights into the US markets one hour before the close of the markets on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Monday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity!
Discover the most active stocks in Monday's session. Stay informed about the stocks that are generating the most trading volume!
Let's take a look at the stocks that are in motion in today's session.
Monday's session: top gainers and losers
Which stocks are gapping on Monday?
The market is buzzing with gapping stocks on Monday. Let's uncover which stocks are experiencing notable gaps during today's session.
CERo Therapeutics, Inc. Presents Preclinical Data Demonstrating CER-1236 Killing Ovarian Cancer Cell Lines Without Toxicity
CERo Therapeutics, Inc. Presents Preclinical Data Demonstrating CER-1236 Killing Ovarian Cancer Cell Lines Without Toxicity
Data presented as part of a poster at the SITC 2024 Conference SOUTH SAN FRANCISCO, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics...
CERo Therapeutics, Inc. Provides Corporate Update
CERo Therapeutics, Inc. Provides Corporate Update
Company announces submission of IND Clinical Hold Complete Response Letter SOUTH SAN FRANCISCO, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- CERo...
CERo Therapeutics, Inc. Names Al Kucharchuk Chief Financial Officer and Kristen Pierce Chief Development Officer
CERo Therapeutics, Inc. Names Al Kucharchuk Chief Financial Officer and Kristen Pierce Chief Development Officer
SOUTH SAN FRANCISCO, Calif, Oct. 02, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy...
CERo Therapeutics, Inc. Announces Financing and Provides Update on Investigational New Drug Application for CER-1236
CERo Therapeutics, Inc. Announces Financing and Provides Update on Investigational New Drug Application for CER-1236
Company requests Type A Meeting with U.S. Food and Drug Administration regarding clinical hold for CER-1236; announces key management changes SOUTH SAN...
CERO Stock Earnings: CERo Therapeutics Hldgs Reported Results for Q2 2024
CERo Therapeutics Hldgs just reported results for the second quarter of 2024.
CERO Stock Earnings: CERo Therapeutics Hldgs Reported Results for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips CERo Therapeutics Hldgs (NASDAQ:CERO) just reported results for the second quar...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Pre-market stock movers are worth diving into as we check out all of the hottest news affecting shares on Monday morning!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic on Thursday morning and we have all of the latest news traders need to know about them!